Director Robert Hershberg filed a Form 4 with the SEC on November 17, 2026, disclosing grants of 282 restricted stock units and 663 director stock options in Danaher Corp /DE/ (NYSE:DHR) on November 15, 2026.

Key Highlights

  • RSU grant: Danaher granted Robert Hershberg 282 restricted stock units on November 15, 2026, at a price of $0, acquired directly.
  • Stock option grant: Hershberg also received 663 director stock options (right to buy) on November 15, 2026, with an exercise price of $233.02 and an expiration date of November 15, 2036.
  • Post-transaction ownership: Following the transactions, Hershberg directly holds 282 shares of common stock and 663 derivative securities.
  • RSU vesting terms: According to the filing, the RSUs vest on the earlier of the first anniversary of the grant date or the date immediately prior to Danaher's next annual shareholder meeting following the grant date.
  • Share delivery timing: The underlying shares from the RSUs are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board, as stated in the filing.
  • Reporting person role: Hershberg is identified as a Director of Danaher Corp /DE/ in the filing.

Danaher Director Hershberg Receives Annual Equity Grants on November 15, 2026

According to the Form 4 filed on November 17, 2026, Danaher Corp /DE/ (NYSE:DHR) granted director Robert Hershberg, MD, Ph.D. two forms of equity compensation on November 15, 2026. The first was an award of 282 restricted stock units, reported in Table I as non-derivative securities acquired at a price of $0. The filing notes that "since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4."

The second grant consisted of 663 director stock options, each carrying a right to buy Danaher common stock at an exercise price of $233.02. The options become exercisable on November 15, 2026, and expire on November 15, 2036, according to the filing. Both grants were acquired with transaction code "A" and are held directly by Hershberg.

The filing explains that the RSUs "vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date." However, the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board. The Form 4 was signed by James F. O'Reilly as attorney-in-fact for Robert Hershberg, MD, Ph.D.

What Was Disclosed

Danaher director Robert Hershberg received grants of 282 RSUs and 663 stock options on November 15, 2026, as reported in a Form 4 filed November 17, 2026. Following these transactions, Hershberg directly holds 282 shares and 663 derivative securities in Danaher Corp /DE/.